MedTrace Logo

CPAP Efficacy in Post-COVID-19 Patients With Sleep Apnea

NCT06052514 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22

Last updated 2025-02-07

No results posted yet for this study

Summary

This is a prospective, observational study evaluating the relationship between severity of sleep apnea with severity of cognitive fog and if treatment of sleep apnea with CPAP improves cognitive fog in a cohort of post COVID patients with sleep apnea.

Conditions

Interventions

DEVICE

Continuous positive airway pressure

Patients with moderate or severe OSA will be treated with CPAP

Sponsors & Collaborators

  • Breathe Pennsylvania

    collaborator UNKNOWN

  • Venkatesh Krishnamurthy

    lead OTHER

Principal Investigators

  • Venkatesh Krishnamurthy, MD · University of Pittsburgh

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-04
Primary Completion
2024-12-21
Completion
2024-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06052514 on ClinicalTrials.gov